LncRNA & Wnt signaling in colorectal cancer
- PMID: 32699525
- PMCID: PMC7372757
- DOI: 10.1186/s12935-020-01412-7
LncRNA & Wnt signaling in colorectal cancer
Abstract
The outlook for new therapeutic approaches is pivotal to ameliorate the deterioration caused by the abrogated Wnt signaling. Long non-coding RNAs (lncRNAs) are tiny molecules that have begun emerging as vital molecular manager for the regulation of various cellular processes at transcription and translation levels in the colorectal cancer (CRC). Targeting Wnt pathway with lncRNA seems a promising approach to eradicate CRC. However, little is known of their active role in commencing both apoptosis and proliferation in CRC. This article reviews the importance of these molecules in the pathogenesis of CRC and also emphasizes on the development of new therapeutic strategies to cope with the Wnt mediated CRC.
Keywords: Colorectal cancer; Therapeutics strategy; Wnt signaling; lncRNA.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsNo competing interest.
Figures
References
-
- SEER S: Stat Database: Incidence—SEER 9 Regs Research Data, November 2013 Sub (1992–2011). Surveillance, Epidemiology, and End Results (SEER) Program 2016.
-
- DESA U: United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2015 revision, key findings and advance tables. Working Paper No. ESA/P/WP. 241; 2015.
-
- Farooqi AA, de la Roche M, Djamgoz MBA, Siddik ZH. Overview of the oncogenic signaling pathways in colorectal cancer: mechanistic insights. Seminars in cancer biology. Cambridge: Academic Press; 2019. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
